loadpatents
name:-0.35999798774719
name:-0.031092882156372
name:-0.00052094459533691
Penco; Sergio Patent Filings

Penco; Sergio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Penco; Sergio.The latest application filed is for "novel dual targeting antitumoral conjugates".

Company Profile
0.31.20
  • Penco; Sergio - Milan IT
  • Penco, Sergio - Rome IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
Grant 8,222,231 - Casu , et al. July 17, 2
2012-07-17
Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
Grant 8,101,793 - Merlini , et al. January 24, 2
2012-01-24
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
Grant 8,067,555 - Casu , et al. November 29, 2
2011-11-29
Novel Dual Targeting Antitumoral Conjugates
App 20110160147 - Dal Pozzo; Alma ;   et al.
2011-06-30
Derivatives Of Partially Desulphated Glycosaminoglycans Endowed With Antiangiogenic Activity And Devoid Of Anticoagulating Effect
App 20100298263 - Casu; Benito ;   et al.
2010-11-25
Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
Grant 7,790,700 - Casu , et al. September 7, 2
2010-09-07
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
Grant 7,781,416 - Casu , et al. August 24, 2
2010-08-24
Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives
Grant 7,728,039 - Pisano , et al. June 1, 2
2010-06-01
Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
Grant 7,705,012 - Pisano , et al. April 27, 2
2010-04-27
7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups
Grant 7,612,081 - Giannini , et al. November 3, 2
2009-11-03
7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
Grant 7,589,099 - Pisano , et al. September 15, 2
2009-09-15
Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives
App 20080319082 - Pisano; Claudio ;   et al.
2008-12-25
Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
Grant 7,449,495 - Dallavalle , et al. November 11, 2
2008-11-11
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
App 20080139503 - Casu; Benito ;   et al.
2008-06-12
7-imino derivatives of camptothecin having antitumor activity
Grant 7,351,714 - Dallavalle , et al. April 1, 2
2008-04-01
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
App 20080051567 - Casu; Benito ;   et al.
2008-02-28
Camptothecins Conjugated in Position 7 to Cyclic Peptides as Cytostatic Agents
App 20080033003 - Pisano; Claudio ;   et al.
2008-02-07
Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities
App 20080021088 - Dallavalle; Sabrina ;   et al.
2008-01-24
Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
App 20070232639 - Pisano; Claudio ;   et al.
2007-10-04
7-T-Butoxyiminomethylcamptothecin Conjugated in Position 20 With Integrin Antagonists
App 20070225311 - Pisano; Claudio ;   et al.
2007-09-27
Cyclopeptide derivatives with anti-integrin activity
App 20070178045 - Pisano; Claudio ;   et al.
2007-08-02
7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups
App 20070043067 - Giannini; Giuseppe ;   et al.
2007-02-22
Bis-heterocyclic compounds with antitumour and chemosensitising activity
App 20060211759 - Giannini; Giuseppe ;   et al.
2006-09-21
Camptothecin derivatives having antitumor activity
Grant 7,105,492 - Dallavalle , et al. September 12, 2
2006-09-12
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
App 20060172968 - Casu; Benito ;   et al.
2006-08-03
Bis-heterocyclic compounds with antitumour and chemosensitising activity
Grant 7,084,166 - Giannini , et al. August 1, 2
2006-08-01
7-Imino derivatives of camptothecin having antitumor activity
App 20060167033 - Dallavalle; Sabrina ;   et al.
2006-07-27
Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
App 20050222084 - Casu, Benito ;   et al.
2005-10-06
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
App 20050137167 - Casu, Benito ;   et al.
2005-06-23
Use of natural chrysanthone compounds having antiangiogenic activity
Grant 6,887,883 - Penco May 3, 2
2005-05-03
Bis-heterocyclic compounds with antitumour and chemosensitising activity
App 20040053987 - Giannini, Giuseppe ;   et al.
2004-03-18
Camptothecin derivatives having antitumor activity
App 20040018988 - Dallavalle, Sabrina ;   et al.
2004-01-29
Industrial process for the production of L-carnitine
Grant 6,566,552 - Tinti , et al. May 20, 2
2003-05-20
Industrial process for the production of L-carnitine
App 20020165408 - Tinti, Maria Ornella ;   et al.
2002-11-07
Camptothecin derivatives having antitumor activity
App 20010008939 - Penco, Sergio ;   et al.
2001-07-19
Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
Grant 5,849,710 - Battistini , et al. December 15, 1
1998-12-15
Camptothecin derivatives and process for their preparation
Grant 5,602,141 - Bedeschi , et al. February 11, 1
1997-02-11
Arylidene-heterocyclic derivatives and process for their preparation
Grant 5,587,385 - Buzzetti , et al. December 24, 1
1996-12-24
Site specific alkylating agents
Grant 5,017,599 - Lazzari , et al. May 21, 1
1991-05-21
Poly-4-aminopyrrole-2-carboxamido derivatives and their use as antiuiral or antitumor agents
Grant 4,766,142 - Arcamone , et al. * August 23, 1
1988-08-23
Morpholino derivatives of daunorubicin and doxorubicin
Grant 4,672,057 - Bargiotti , et al. June 9, 1
1987-06-09
Anthracycline glycosides, use and compositions containing same
Grant 4,563,444 - Angelucci , et al. January 7, 1
1986-01-07
Antracycline glycosides, pharmaceutical compositions and method of use
Grant 4,477,444 - Suarato , et al. October 16, 1
1984-10-16
4'-Iododerivatives of anthracycline glycosides
Grant 4,438,105 - Suarato , et al. March 20, 1
1984-03-20
Antitumor anthracycline glycosides, their preparation, intermediates therefor, and compositions and use thereof
Grant 4,366,149 - Bargiotti , et al. December 28, 1
1982-12-28
Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process
Grant 4,345,068 - Suarato , et al. August 17, 1
1982-08-17
Process for the preparation of 4'-deoxy-daunorubicin and 4'-deoxy-doxorubicin
Grant 4,345,070 - Suarato , et al. August 17, 1
1982-08-17
Epi-daunomycin and epi-adriamycin compounds and method of use
Grant 4,112,076 - Arcamone , et al. September 5, 1
1978-09-05
Process for preparing daunomycin and analogues thereof
Grant 4,107,423 - Arcamone , et al. August 15, 1
1978-08-15
Adriamycins and uses thereof
Grant 4,058,519 - Arcamone , et al. November 15, 1
1977-11-15
Daunomycins, process for their uses and intermediates
Grant 4,039,663 - Arcamone , et al. August 2, 1
1977-08-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed